FDA Inspection
Davion IncDavion Inc – FDA Inspection, Jul 17, 2024
Record Details
This FDA Inspection record concerns Davion Inc, with an inspection on July 17, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d11921da-7e4b-4f79-8783-617f090f8c6f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1243953
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.84(c)(2)Containers sampled so as to prevent contamination
- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.180(e)(1)Representative Number of Batches for Annual Review
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Davion Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 2, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Davion Inc
- FDA Inspection 970070 - 2016-05-02
- FDA Inspection 780794 - 2012-05-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.